Back to Results
First PageMeta Content
Pharmaceutical industry / Biotechnology / Food and Drug Administration / Monoclonal antibodies / Biosimilar / Biologic / Declaratory judgment / Centocor / Infliximab / Pharmacology / Pharmaceutical sciences / Medicine


Microsoft Word - 106937148_19
Add to Reading List

Document Date: 2014-05-29 15:29:36

Open Document

File Size: 159,46 KB

Share Result on Facebook

Company

SanDisk Corp. / Gould / CELLTRION INC. / Amgen Inc. / Centocor Ortho Biotech Inc. / Nucleonics Inc. / Kinetic Concepts Inc. / A. Pharmaceuticals / BACKGROUND A. Pharmaceuticals / MedImmune Inc. / CASES Arkema Inc. / Its Complaint Celltrion / Sandoz Inc. / 26 I. INTRODUCTION Celltrion Healthcare Co. Ltd / Medicis Pharm / Tech LLC / Danisco U.S. Inc. / Ventritex Inc. / TubeMaster Inc. / Honeywell / MASSACHUSETTS CELLTRION HEALTHCARE CO. LTD. / Centocor Inc. / Prasco LLC / Genentech Inc. / Janssen U.S. / Abbott Labs. / Novozymes A/S / JANSSEN BIOTECH INC. / B. Janssen Biotech Inc. / The BPCIA / STMicroelectronics Inc. / Therapies Inc. / Control Laser Corp. / 26 Sandoz Inc. / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / M&A / Patent Filing / Legal Issues / /

Facility

Hospital Bella Vista / /

IndustryTerm

immune systems / reference product / biosimilars manufacturer / biologic manufacturing process / biologic product / follow-on manufacturer / laboratory using well-understood chemical reactions / precise chemical structures / treatment of a chronic disease / treatment of Crohn’s Disease / potential biosimilar manufacturer / reference products / pharmaceutical products / /

MedicalCondition

spondylitis / rheumatoid arthritis / plaque psoriasis / OF INJURY / psoriatic arthritis / disease / TNFα-mediated disease / Crohn’s Disease / ulcerative colitis / chronic disease / /

Organization

Legal Authority / Rockefeller Univ. / Congress / United States Patent and Trademark Office / UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS CELLTRION HEALTHCARE CO. / US Federal Reserve / FDA / /

Person

Krista H. Carver / Jay Siegel / Jason Weil / John R. Thomas / /

Position

important player / leader in the development / /

Product

Remicade / Remsima / R41483 / Remicade® / 26 drug / United States / /

Technology

antibodies / /

SocialTag